nodes	percent_of_prediction	percent_of_DWPC	metapath
Mechlorethamine—Skin bacterial infection—Mometasone—systemic scleroderma	0.194	0.194	CcSEcCtD
Mechlorethamine—Skin carcinoma—Mycophenolic acid—systemic scleroderma	0.0283	0.0283	CcSEcCtD
Mechlorethamine—Skin cancer—Azathioprine—systemic scleroderma	0.023	0.023	CcSEcCtD
Mechlorethamine—Skin carcinoma—Mycophenolate mofetil—systemic scleroderma	0.0223	0.0223	CcSEcCtD
Mechlorethamine—Skin cancer—Mycophenolic acid—systemic scleroderma	0.0207	0.0207	CcSEcCtD
Mechlorethamine—Skin cancer—Mycophenolate mofetil—systemic scleroderma	0.0163	0.0163	CcSEcCtD
Mechlorethamine—Lymphopenia—Mycophenolic acid—systemic scleroderma	0.0125	0.0125	CcSEcCtD
Mechlorethamine—Blister—Captopril—systemic scleroderma	0.0113	0.0113	CcSEcCtD
Mechlorethamine—Azotaemia—Lisinopril—systemic scleroderma	0.0109	0.0109	CcSEcCtD
Mechlorethamine—Azoospermia—Methotrexate—systemic scleroderma	0.0107	0.0107	CcSEcCtD
Mechlorethamine—Azotaemia—Mycophenolate mofetil—systemic scleroderma	0.00951	0.00951	CcSEcCtD
Mechlorethamine—Herpes zoster—Azathioprine—systemic scleroderma	0.00946	0.00946	CcSEcCtD
Mechlorethamine—Thrombosis—Mycophenolic acid—systemic scleroderma	0.00907	0.00907	CcSEcCtD
Mechlorethamine—Herpes zoster—Leflunomide—systemic scleroderma	0.00893	0.00893	CcSEcCtD
Mechlorethamine—Oliguria—Captopril—systemic scleroderma	0.00886	0.00886	CcSEcCtD
Mechlorethamine—Skin ulcer—Leflunomide—systemic scleroderma	0.00864	0.00864	CcSEcCtD
Mechlorethamine—Herpes zoster—Mycophenolic acid—systemic scleroderma	0.00852	0.00852	CcSEcCtD
Mechlorethamine—Skin ulcer—Mycophenolic acid—systemic scleroderma	0.00824	0.00824	CcSEcCtD
Mechlorethamine—Petechiae—Mycophenolic acid—systemic scleroderma	0.0078	0.0078	CcSEcCtD
Mechlorethamine—Herpes zoster—Lisinopril—systemic scleroderma	0.00768	0.00768	CcSEcCtD
Mechlorethamine—Thrombosis—Mycophenolate mofetil—systemic scleroderma	0.00716	0.00716	CcSEcCtD
Mechlorethamine—Oliguria—Mycophenolic acid—systemic scleroderma	0.00696	0.00696	CcSEcCtD
Mechlorethamine—Herpes zoster—Mycophenolate mofetil—systemic scleroderma	0.00673	0.00673	CcSEcCtD
Mechlorethamine—Lymphopenia—Prednisone—systemic scleroderma	0.00671	0.00671	CcSEcCtD
Mechlorethamine—Haemolytic anaemia—Captopril—systemic scleroderma	0.00656	0.00656	CcSEcCtD
Mechlorethamine—Skin ulcer—Mycophenolate mofetil—systemic scleroderma	0.00651	0.00651	CcSEcCtD
Mechlorethamine—Pancytopenia—Pentoxifylline—systemic scleroderma	0.00642	0.00642	CcSEcCtD
Mechlorethamine—Oliguria—Lisinopril—systemic scleroderma	0.00627	0.00627	CcSEcCtD
Mechlorethamine—Dermatitis bullous—Captopril—systemic scleroderma	0.0062	0.0062	CcSEcCtD
Mechlorethamine—Petechiae—Mycophenolate mofetil—systemic scleroderma	0.00616	0.00616	CcSEcCtD
Mechlorethamine—Jaundice—Pentoxifylline—systemic scleroderma	0.00587	0.00587	CcSEcCtD
Mechlorethamine—Amenorrhoea—Mycophenolate mofetil—systemic scleroderma	0.00576	0.00576	CcSEcCtD
Mechlorethamine—Oliguria—Mycophenolate mofetil—systemic scleroderma	0.0055	0.0055	CcSEcCtD
Mechlorethamine—Haemoglobin—Pentoxifylline—systemic scleroderma	0.00544	0.00544	CcSEcCtD
Mechlorethamine—Haemorrhage—Pentoxifylline—systemic scleroderma	0.00541	0.00541	CcSEcCtD
Mechlorethamine—Azotaemia—Methotrexate—systemic scleroderma	0.00539	0.00539	CcSEcCtD
Mechlorethamine—Dermatitis bullous—Mycophenolic acid—systemic scleroderma	0.00487	0.00487	CcSEcCtD
Mechlorethamine—Pancytopenia—Captopril—systemic scleroderma	0.00486	0.00486	CcSEcCtD
Mechlorethamine—Skin hyperpigmentation—Methotrexate—systemic scleroderma	0.00482	0.00482	CcSEcCtD
Mechlorethamine—Haemolytic anaemia—Lisinopril—systemic scleroderma	0.00465	0.00465	CcSEcCtD
Mechlorethamine—Jaundice—Captopril—systemic scleroderma	0.00445	0.00445	CcSEcCtD
Mechlorethamine—Agranulocytosis—Captopril—systemic scleroderma	0.00426	0.00426	CcSEcCtD
Mechlorethamine—Thrombophlebitis—Mycophenolate mofetil—systemic scleroderma	0.00425	0.00425	CcSEcCtD
Mechlorethamine—Pancytopenia—Azathioprine—systemic scleroderma	0.00424	0.00424	CcSEcCtD
Mechlorethamine—Leukopenia—Pentoxifylline—systemic scleroderma	0.00421	0.00421	CcSEcCtD
Mechlorethamine—Petechiae—Prednisone—systemic scleroderma	0.00417	0.00417	CcSEcCtD
Mechlorethamine—Haemolytic anaemia—Mycophenolate mofetil—systemic scleroderma	0.00407	0.00407	CcSEcCtD
Mechlorethamine—Pancytopenia—Leflunomide—systemic scleroderma	0.00401	0.00401	CcSEcCtD
Mechlorethamine—Unspecified disorder of skin and subcutaneous tissue—Pentoxifylline—systemic scleroderma	0.00398	0.00398	CcSEcCtD
Mechlorethamine—Amenorrhoea—Prednisone—systemic scleroderma	0.00391	0.00391	CcSEcCtD
Mechlorethamine—Erythema multiforme—Captopril—systemic scleroderma	0.00388	0.00388	CcSEcCtD
Mechlorethamine—Dermatitis bullous—Mycophenolate mofetil—systemic scleroderma	0.00385	0.00385	CcSEcCtD
Mechlorethamine—Anaphylactic shock—Pentoxifylline—systemic scleroderma	0.00384	0.00384	CcSEcCtD
Mechlorethamine—Pancytopenia—Mycophenolic acid—systemic scleroderma	0.00382	0.00382	CcSEcCtD
Mechlorethamine—Infection—Pentoxifylline—systemic scleroderma	0.00382	0.00382	CcSEcCtD
Mechlorethamine—Herpes zoster—Methotrexate—systemic scleroderma	0.00381	0.00381	CcSEcCtD
Mechlorethamine—Thrombocytopenia—Pentoxifylline—systemic scleroderma	0.00376	0.00376	CcSEcCtD
Mechlorethamine—Skin disorder—Pentoxifylline—systemic scleroderma	0.00373	0.00373	CcSEcCtD
Mechlorethamine—Agranulocytosis—Azathioprine—systemic scleroderma	0.00372	0.00372	CcSEcCtD
Mechlorethamine—Skin ulcer—Methotrexate—systemic scleroderma	0.00369	0.00369	CcSEcCtD
Mechlorethamine—Jaundice—Leflunomide—systemic scleroderma	0.00367	0.00367	CcSEcCtD
Mechlorethamine—Anorexia—Pentoxifylline—systemic scleroderma	0.00366	0.00366	CcSEcCtD
Mechlorethamine—Alopecia—Captopril—systemic scleroderma	0.00362	0.00362	CcSEcCtD
Mechlorethamine—Haemoglobin—Azathioprine—systemic scleroderma	0.0036	0.0036	CcSEcCtD
Mechlorethamine—Haemorrhage—Azathioprine—systemic scleroderma	0.00358	0.00358	CcSEcCtD
Mechlorethamine—Agranulocytosis—Leflunomide—systemic scleroderma	0.00351	0.00351	CcSEcCtD
Mechlorethamine—Jaundice—Mycophenolic acid—systemic scleroderma	0.0035	0.0035	CcSEcCtD
Mechlorethamine—Petechiae—Methotrexate—systemic scleroderma	0.00349	0.00349	CcSEcCtD
Mechlorethamine—Pancytopenia—Lisinopril—systemic scleroderma	0.00344	0.00344	CcSEcCtD
Mechlorethamine—Haemoglobin—Leflunomide—systemic scleroderma	0.0034	0.0034	CcSEcCtD
Mechlorethamine—Erythema multiforme—Azathioprine—systemic scleroderma	0.00338	0.00338	CcSEcCtD
Mechlorethamine—Haemorrhage—Leflunomide—systemic scleroderma	0.00338	0.00338	CcSEcCtD
Mechlorethamine—Agranulocytosis—Mycophenolic acid—systemic scleroderma	0.00335	0.00335	CcSEcCtD
Mechlorethamine—Decreased appetite—Pentoxifylline—systemic scleroderma	0.00334	0.00334	CcSEcCtD
Mechlorethamine—Anaphylactic shock—Mometasone—systemic scleroderma	0.00332	0.00332	CcSEcCtD
Mechlorethamine—Infection—Mometasone—systemic scleroderma	0.00329	0.00329	CcSEcCtD
Mechlorethamine—Haemoglobin—Mycophenolic acid—systemic scleroderma	0.00324	0.00324	CcSEcCtD
Mechlorethamine—Depression—Lisinopril—systemic scleroderma	0.00322	0.00322	CcSEcCtD
Mechlorethamine—Haemorrhage—Mycophenolic acid—systemic scleroderma	0.00322	0.00322	CcSEcCtD
Mechlorethamine—Erythema multiforme—Leflunomide—systemic scleroderma	0.00319	0.00319	CcSEcCtD
Mechlorethamine—Alopecia—Azathioprine—systemic scleroderma	0.00316	0.00316	CcSEcCtD
Mechlorethamine—Anorexia—Mometasone—systemic scleroderma	0.00316	0.00316	CcSEcCtD
Mechlorethamine—Jaundice—Lisinopril—systemic scleroderma	0.00315	0.00315	CcSEcCtD
Mechlorethamine—Oliguria—Methotrexate—systemic scleroderma	0.00311	0.00311	CcSEcCtD
Mechlorethamine—Pancytopenia—Mycophenolate mofetil—systemic scleroderma	0.00302	0.00302	CcSEcCtD
Mechlorethamine—Agranulocytosis—Lisinopril—systemic scleroderma	0.00302	0.00302	CcSEcCtD
Mechlorethamine—Tinnitus—Mycophenolic acid—systemic scleroderma	0.00301	0.00301	CcSEcCtD
Mechlorethamine—Alopecia—Leflunomide—systemic scleroderma	0.00299	0.00299	CcSEcCtD
Mechlorethamine—Anaphylactic shock—Captopril—systemic scleroderma	0.00291	0.00291	CcSEcCtD
Mechlorethamine—Decreased appetite—Mometasone—systemic scleroderma	0.00288	0.00288	CcSEcCtD
Mechlorethamine—Thrombophlebitis—Prednisone—systemic scleroderma	0.00288	0.00288	CcSEcCtD
Mechlorethamine—Thrombocytopenia—Captopril—systemic scleroderma	0.00285	0.00285	CcSEcCtD
Mechlorethamine—Alopecia—Mycophenolic acid—systemic scleroderma	0.00285	0.00285	CcSEcCtD
Mechlorethamine—Hypersensitivity—Pentoxifylline—systemic scleroderma	0.00283	0.00283	CcSEcCtD
Mechlorethamine—Depression—Mycophenolate mofetil—systemic scleroderma	0.00283	0.00283	CcSEcCtD
Mechlorethamine—Leukopenia—Azathioprine—systemic scleroderma	0.00279	0.00279	CcSEcCtD
Mechlorethamine—Anorexia—Captopril—systemic scleroderma	0.00278	0.00278	CcSEcCtD
Mechlorethamine—Jaundice—Mycophenolate mofetil—systemic scleroderma	0.00276	0.00276	CcSEcCtD
Mechlorethamine—Erythema multiforme—Lisinopril—systemic scleroderma	0.00274	0.00274	CcSEcCtD
Mechlorethamine—Pruritus—Pentoxifylline—systemic scleroderma	0.00272	0.00272	CcSEcCtD
Mechlorethamine—Tinnitus—Lisinopril—systemic scleroderma	0.00271	0.00271	CcSEcCtD
Mechlorethamine—Agranulocytosis—Mycophenolate mofetil—systemic scleroderma	0.00264	0.00264	CcSEcCtD
Mechlorethamine—Vertigo—Leflunomide—systemic scleroderma	0.00264	0.00264	CcSEcCtD
Mechlorethamine—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—systemic scleroderma	0.00263	0.00263	CcSEcCtD
Mechlorethamine—Leukopenia—Leflunomide—systemic scleroderma	0.00263	0.00263	CcSEcCtD
Mechlorethamine—Diarrhoea—Pentoxifylline—systemic scleroderma	0.00263	0.00263	CcSEcCtD
Mechlorethamine—Alopecia—Lisinopril—systemic scleroderma	0.00257	0.00257	CcSEcCtD
Mechlorethamine—Haemoglobin—Mycophenolate mofetil—systemic scleroderma	0.00256	0.00256	CcSEcCtD
Mechlorethamine—Haemorrhage—Mycophenolate mofetil—systemic scleroderma	0.00254	0.00254	CcSEcCtD
Mechlorethamine—Decreased appetite—Captopril—systemic scleroderma	0.00253	0.00253	CcSEcCtD
Mechlorethamine—Infection—Azathioprine—systemic scleroderma	0.00253	0.00253	CcSEcCtD
Mechlorethamine—Vertigo—Mycophenolic acid—systemic scleroderma	0.00252	0.00252	CcSEcCtD
Mechlorethamine—Leukopenia—Mycophenolic acid—systemic scleroderma	0.00251	0.00251	CcSEcCtD
Mechlorethamine—Thrombocytopenia—Azathioprine—systemic scleroderma	0.00249	0.00249	CcSEcCtD
Mechlorethamine—Unspecified disorder of skin and subcutaneous tissue—Leflunomide—systemic scleroderma	0.00249	0.00249	CcSEcCtD
Mechlorethamine—Skin disorder—Azathioprine—systemic scleroderma	0.00247	0.00247	CcSEcCtD
Mechlorethamine—Vomiting—Pentoxifylline—systemic scleroderma	0.00244	0.00244	CcSEcCtD
Mechlorethamine—Rash—Pentoxifylline—systemic scleroderma	0.00242	0.00242	CcSEcCtD
Mechlorethamine—Dermatitis—Pentoxifylline—systemic scleroderma	0.00242	0.00242	CcSEcCtD
Mechlorethamine—Thrombophlebitis—Methotrexate—systemic scleroderma	0.00241	0.00241	CcSEcCtD
Mechlorethamine—Anaphylactic shock—Leflunomide—systemic scleroderma	0.0024	0.0024	CcSEcCtD
Mechlorethamine—Infection—Leflunomide—systemic scleroderma	0.00238	0.00238	CcSEcCtD
Mechlorethamine—Unspecified disorder of skin and subcutaneous tissue—Mycophenolic acid—systemic scleroderma	0.00237	0.00237	CcSEcCtD
Mechlorethamine—Tinnitus—Mycophenolate mofetil—systemic scleroderma	0.00237	0.00237	CcSEcCtD
Mechlorethamine—Thrombocytopenia—Leflunomide—systemic scleroderma	0.00235	0.00235	CcSEcCtD
Mechlorethamine—Pruritus—Mometasone—systemic scleroderma	0.00235	0.00235	CcSEcCtD
Mechlorethamine—Skin disorder—Leflunomide—systemic scleroderma	0.00233	0.00233	CcSEcCtD
Mechlorethamine—Anorexia—Leflunomide—systemic scleroderma	0.00229	0.00229	CcSEcCtD
Mechlorethamine—Nausea—Pentoxifylline—systemic scleroderma	0.00228	0.00228	CcSEcCtD
Mechlorethamine—Infection—Mycophenolic acid—systemic scleroderma	0.00227	0.00227	CcSEcCtD
Mechlorethamine—Vertigo—Lisinopril—systemic scleroderma	0.00227	0.00227	CcSEcCtD
Mechlorethamine—Diarrhoea—Mometasone—systemic scleroderma	0.00227	0.00227	CcSEcCtD
Mechlorethamine—Leukopenia—Lisinopril—systemic scleroderma	0.00226	0.00226	CcSEcCtD
Mechlorethamine—Alopecia—Mycophenolate mofetil—systemic scleroderma	0.00225	0.00225	CcSEcCtD
Mechlorethamine—Thrombocytopenia—Mycophenolic acid—systemic scleroderma	0.00224	0.00224	CcSEcCtD
Mechlorethamine—Skin disorder—Mycophenolic acid—systemic scleroderma	0.00222	0.00222	CcSEcCtD
Mechlorethamine—Anorexia—Mycophenolic acid—systemic scleroderma	0.00218	0.00218	CcSEcCtD
Mechlorethamine—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—systemic scleroderma	0.00214	0.00214	CcSEcCtD
Mechlorethamine—Vomiting—Mometasone—systemic scleroderma	0.00211	0.00211	CcSEcCtD
Mechlorethamine—Rash—Mometasone—systemic scleroderma	0.00209	0.00209	CcSEcCtD
Mechlorethamine—Dermatitis—Mometasone—systemic scleroderma	0.00209	0.00209	CcSEcCtD
Mechlorethamine—Decreased appetite—Leflunomide—systemic scleroderma	0.00209	0.00209	CcSEcCtD
Mechlorethamine—Anaphylactic shock—Lisinopril—systemic scleroderma	0.00206	0.00206	CcSEcCtD
Mechlorethamine—Pruritus—Captopril—systemic scleroderma	0.00206	0.00206	CcSEcCtD
Mechlorethamine—Infection—Lisinopril—systemic scleroderma	0.00205	0.00205	CcSEcCtD
Mechlorethamine—Thrombocytopenia—Lisinopril—systemic scleroderma	0.00202	0.00202	CcSEcCtD
Mechlorethamine—Skin disorder—Lisinopril—systemic scleroderma	0.002	0.002	CcSEcCtD
Mechlorethamine—Diarrhoea—Captopril—systemic scleroderma	0.00199	0.00199	CcSEcCtD
Mechlorethamine—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.00199	0.00199	CcSEcCtD
Mechlorethamine—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.00199	0.00199	CcSEcCtD
Mechlorethamine—Leukopenia—Mycophenolate mofetil—systemic scleroderma	0.00198	0.00198	CcSEcCtD
Mechlorethamine—Nausea—Mometasone—systemic scleroderma	0.00197	0.00197	CcSEcCtD
Mechlorethamine—Anorexia—Lisinopril—systemic scleroderma	0.00197	0.00197	CcSEcCtD
Mechlorethamine—Depression—Prednisone—systemic scleroderma	0.00192	0.00192	CcSEcCtD
Mechlorethamine—Hypersensitivity—Azathioprine—systemic scleroderma	0.00187	0.00187	CcSEcCtD
Mechlorethamine—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.00187	0.00187	CcSEcCtD
Mechlorethamine—Vomiting—Captopril—systemic scleroderma	0.00185	0.00185	CcSEcCtD
Mechlorethamine—Rash—Captopril—systemic scleroderma	0.00184	0.00184	CcSEcCtD
Mechlorethamine—Dermatitis—Captopril—systemic scleroderma	0.00183	0.00183	CcSEcCtD
Mechlorethamine—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.00181	0.00181	CcSEcCtD
Mechlorethamine—Infection—Mycophenolate mofetil—systemic scleroderma	0.0018	0.0018	CcSEcCtD
Mechlorethamine—Decreased appetite—Lisinopril—systemic scleroderma	0.00179	0.00179	CcSEcCtD
Mechlorethamine—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.00177	0.00177	CcSEcCtD
Mechlorethamine—Hypersensitivity—Leflunomide—systemic scleroderma	0.00177	0.00177	CcSEcCtD
Mechlorethamine—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.00176	0.00176	CcSEcCtD
Mechlorethamine—Diarrhoea—Azathioprine—systemic scleroderma	0.00174	0.00174	CcSEcCtD
Mechlorethamine—Haemoglobin—Prednisone—systemic scleroderma	0.00173	0.00173	CcSEcCtD
Mechlorethamine—Nausea—Captopril—systemic scleroderma	0.00173	0.00173	CcSEcCtD
Mechlorethamine—Haemorrhage—Prednisone—systemic scleroderma	0.00172	0.00172	CcSEcCtD
Mechlorethamine—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.00172	0.00172	CcSEcCtD
Mechlorethamine—Pancytopenia—Methotrexate—systemic scleroderma	0.00171	0.00171	CcSEcCtD
Mechlorethamine—Pruritus—Leflunomide—systemic scleroderma	0.0017	0.0017	CcSEcCtD
Mechlorethamine—Diarrhoea—Leflunomide—systemic scleroderma	0.00164	0.00164	CcSEcCtD
Mechlorethamine—Pruritus—Mycophenolic acid—systemic scleroderma	0.00162	0.00162	CcSEcCtD
Mechlorethamine—Vomiting—Azathioprine—systemic scleroderma	0.00162	0.00162	CcSEcCtD
Mechlorethamine—Rash—Azathioprine—systemic scleroderma	0.0016	0.0016	CcSEcCtD
Mechlorethamine—Dermatitis—Azathioprine—systemic scleroderma	0.0016	0.0016	CcSEcCtD
Mechlorethamine—Depression—Methotrexate—systemic scleroderma	0.0016	0.0016	CcSEcCtD
Mechlorethamine—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.00157	0.00157	CcSEcCtD
Mechlorethamine—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.00157	0.00157	CcSEcCtD
Mechlorethamine—Vomiting—Leflunomide—systemic scleroderma	0.00153	0.00153	CcSEcCtD
Mechlorethamine—Alopecia—Prednisone—systemic scleroderma	0.00152	0.00152	CcSEcCtD
Mechlorethamine—Hypersensitivity—Lisinopril—systemic scleroderma	0.00152	0.00152	CcSEcCtD
Mechlorethamine—Rash—Leflunomide—systemic scleroderma	0.00151	0.00151	CcSEcCtD
Mechlorethamine—Dermatitis—Leflunomide—systemic scleroderma	0.00151	0.00151	CcSEcCtD
Mechlorethamine—Nausea—Azathioprine—systemic scleroderma	0.00151	0.00151	CcSEcCtD
Mechlorethamine—Agranulocytosis—Methotrexate—systemic scleroderma	0.0015	0.0015	CcSEcCtD
Mechlorethamine—Pruritus—Lisinopril—systemic scleroderma	0.00146	0.00146	CcSEcCtD
Mechlorethamine—Vomiting—Mycophenolic acid—systemic scleroderma	0.00146	0.00146	CcSEcCtD
Mechlorethamine—Haemoglobin—Methotrexate—systemic scleroderma	0.00145	0.00145	CcSEcCtD
Mechlorethamine—Rash—Mycophenolic acid—systemic scleroderma	0.00144	0.00144	CcSEcCtD
Mechlorethamine—Dermatitis—Mycophenolic acid—systemic scleroderma	0.00144	0.00144	CcSEcCtD
Mechlorethamine—Haemorrhage—Methotrexate—systemic scleroderma	0.00144	0.00144	CcSEcCtD
Mechlorethamine—Nausea—Leflunomide—systemic scleroderma	0.00143	0.00143	CcSEcCtD
Mechlorethamine—Diarrhoea—Lisinopril—systemic scleroderma	0.00141	0.00141	CcSEcCtD
Mechlorethamine—Erythema multiforme—Methotrexate—systemic scleroderma	0.00136	0.00136	CcSEcCtD
Mechlorethamine—Nausea—Mycophenolic acid—systemic scleroderma	0.00136	0.00136	CcSEcCtD
Mechlorethamine—Vertigo—Prednisone—systemic scleroderma	0.00135	0.00135	CcSEcCtD
Mechlorethamine—Tinnitus—Methotrexate—systemic scleroderma	0.00134	0.00134	CcSEcCtD
Mechlorethamine—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.00133	0.00133	CcSEcCtD
Mechlorethamine—Vomiting—Lisinopril—systemic scleroderma	0.00131	0.00131	CcSEcCtD
Mechlorethamine—Rash—Lisinopril—systemic scleroderma	0.0013	0.0013	CcSEcCtD
Mechlorethamine—Dermatitis—Lisinopril—systemic scleroderma	0.0013	0.0013	CcSEcCtD
Mechlorethamine—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.00128	0.00128	CcSEcCtD
Mechlorethamine—Alopecia—Methotrexate—systemic scleroderma	0.00127	0.00127	CcSEcCtD
Mechlorethamine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.00127	0.00127	CcSEcCtD
Mechlorethamine—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.00124	0.00124	CcSEcCtD
Mechlorethamine—Nausea—Lisinopril—systemic scleroderma	0.00123	0.00123	CcSEcCtD
Mechlorethamine—Anaphylactic shock—Prednisone—systemic scleroderma	0.00122	0.00122	CcSEcCtD
Mechlorethamine—Infection—Prednisone—systemic scleroderma	0.00122	0.00122	CcSEcCtD
Mechlorethamine—Skin disorder—Prednisone—systemic scleroderma	0.00119	0.00119	CcSEcCtD
Mechlorethamine—Anorexia—Prednisone—systemic scleroderma	0.00117	0.00117	CcSEcCtD
Mechlorethamine—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.00115	0.00115	CcSEcCtD
Mechlorethamine—Rash—Mycophenolate mofetil—systemic scleroderma	0.00114	0.00114	CcSEcCtD
Mechlorethamine—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.00114	0.00114	CcSEcCtD
Mechlorethamine—Vertigo—Methotrexate—systemic scleroderma	0.00113	0.00113	CcSEcCtD
Mechlorethamine—Leukopenia—Methotrexate—systemic scleroderma	0.00112	0.00112	CcSEcCtD
Mechlorethamine—Nausea—Mycophenolate mofetil—systemic scleroderma	0.00107	0.00107	CcSEcCtD
Mechlorethamine—Decreased appetite—Prednisone—systemic scleroderma	0.00106	0.00106	CcSEcCtD
Mechlorethamine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.00106	0.00106	CcSEcCtD
Mechlorethamine—Anaphylactic shock—Methotrexate—systemic scleroderma	0.00102	0.00102	CcSEcCtD
Mechlorethamine—Infection—Methotrexate—systemic scleroderma	0.00102	0.00102	CcSEcCtD
Mechlorethamine—Thrombocytopenia—Methotrexate—systemic scleroderma	0.001	0.001	CcSEcCtD
Mechlorethamine—Skin disorder—Methotrexate—systemic scleroderma	0.000994	0.000994	CcSEcCtD
Mechlorethamine—Anorexia—Methotrexate—systemic scleroderma	0.000976	0.000976	CcSEcCtD
Mechlorethamine—Hypersensitivity—Prednisone—systemic scleroderma	0.000903	0.000903	CcSEcCtD
Mechlorethamine—Decreased appetite—Methotrexate—systemic scleroderma	0.00089	0.00089	CcSEcCtD
Mechlorethamine—Pruritus—Prednisone—systemic scleroderma	0.000867	0.000867	CcSEcCtD
Mechlorethamine—Diarrhoea—Prednisone—systemic scleroderma	0.000838	0.000838	CcSEcCtD
Mechlorethamine—Vomiting—Prednisone—systemic scleroderma	0.000779	0.000779	CcSEcCtD
Mechlorethamine—Rash—Prednisone—systemic scleroderma	0.000772	0.000772	CcSEcCtD
Mechlorethamine—Dermatitis—Prednisone—systemic scleroderma	0.000772	0.000772	CcSEcCtD
Mechlorethamine—Hypersensitivity—Methotrexate—systemic scleroderma	0.000754	0.000754	CcSEcCtD
Mechlorethamine—Nausea—Prednisone—systemic scleroderma	0.000728	0.000728	CcSEcCtD
Mechlorethamine—Pruritus—Methotrexate—systemic scleroderma	0.000724	0.000724	CcSEcCtD
Mechlorethamine—Diarrhoea—Methotrexate—systemic scleroderma	0.0007	0.0007	CcSEcCtD
Mechlorethamine—Vomiting—Methotrexate—systemic scleroderma	0.000651	0.000651	CcSEcCtD
Mechlorethamine—Rash—Methotrexate—systemic scleroderma	0.000645	0.000645	CcSEcCtD
Mechlorethamine—Dermatitis—Methotrexate—systemic scleroderma	0.000645	0.000645	CcSEcCtD
Mechlorethamine—Nausea—Methotrexate—systemic scleroderma	0.000608	0.000608	CcSEcCtD
